Christine Cassiano
Consultant / Advisor bei UROGEN PHARMA LTD.
Profil
Christine Cassiano is a Strategic Communications Advisor to Vida Ventures.
She is a communications executive with wide experience in investor relations, financial communications, corporate communications, media relations, brand strategy and public affairs.
Christine previously served as Senior Vice President of Corporate Communications and Investor Relations for Kite Pharma until the acquisition of Kite by Gilead Sciences in 2017.
She has also held senior global communications roles in biotechnology and pharmaceutical companies such as Amgen, Allergan and Abraxis BioScience.
Some of Christine’s career achievements include a SABRE Silver Anvil award for the launch of Botox® Cosmetic (Allergan), an In2 SABRE Award for the Most Innovative Brand/Agency Collaboration (Pfizer/ARC2), and PR Week’s 40 Under 40.
She holds a B.A.
from California State University, Fullerton and Investor Relations Certification (IRC) from the University of California, Irvine.
Aktive Positionen von Christine Cassiano
| Unternehmen | Position | Beginn |
|---|---|---|
| UROGEN PHARMA LTD. | Consultant / Advisor | 01.01.2018 |
| ALLOGENE THERAPEUTICS, INC. | General Counsel | 01.03.2018 |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Consultant / Advisor | 01.12.2017 |
Ehemalige bekannte Positionen von Christine Cassiano
| Unternehmen | Position | Ende |
|---|---|---|
| KRONOS BIO, INC. | Consultant / Advisor | 01.12.2019 |
| KITE PHARMA INC | Investor Relations Contact | 01.12.2017 |
ARC2 Communications & Media, Inc.
 ARC2 Communications & Media, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Real Chemistry, Inc., ARC2 Communications & Media, Inc. provides healthcare communications agency services. The private company is based in Los Angeles, CA. The company was founded by Christine Cassiano. ARC2 Communications & Media was acquired by Real Chemistry, Inc. on February 18, 2015. | Founder | 01.01.2015 |
Hill+Knowlton Strategies LLC
 Hill+Knowlton Strategies LLC Miscellaneous Commercial ServicesCommercial Services Hill+Knowlton Strategies LLC provide international communications consultancy services. It helps brands and the public communicate. The firm offers senior counsel, insightful research and strategic communications throughout the world. The company was founded in 1964 and is headquartered in New York, NY. | Director/Board Member | 01.01.2012 |
Abraxis BioScience, Inc. /Old/
 Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | Director/Board Member | 15.11.2007 |
Ausbildung von Christine Cassiano
| The California State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| UROGEN PHARMA LTD. | Health Technology |
| ALLOGENE THERAPEUTICS, INC. | Health Technology |
| KRONOS BIO, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
APP Pharmaceuticals, Inc.
 APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA. | Health Technology |
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | Health Technology |
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
Hill+Knowlton Strategies LLC
Hill+Knowlton Strategies LLC Miscellaneous Commercial ServicesCommercial Services Hill+Knowlton Strategies LLC provide international communications consultancy services. It helps brands and the public communicate. The firm offers senior counsel, insightful research and strategic communications throughout the world. The company was founded in 1964 and is headquartered in New York, NY. | Commercial Services |
Real Chemistry, Inc.
 Real Chemistry, Inc. Data Processing ServicesTechnology Services Real Chemistry, Inc. is an end-to-end healthcare experience group that leverages advanced AI-powered insights, diverse expertise, and customer-centric ideas to transform the healthcare industry. Real Chemistry is based in New York, NY and has subsidiaries in Canada, United Kingdom, and United States. The company helps healthcare professionals better understand, reach, and engage patients, while creating healthcare experiences that span diagnosis to adherence. The company was founded in 2001 by Jim Weiss. Shankar Narayanan has been the CEO of the company since 2022. | Technology Services |
ARC2 Communications & Media, Inc.
ARC2 Communications & Media, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Real Chemistry, Inc., ARC2 Communications & Media, Inc. provides healthcare communications agency services. The private company is based in Los Angeles, CA. The company was founded by Christine Cassiano. ARC2 Communications & Media was acquired by Real Chemistry, Inc. on February 18, 2015. | Commercial Services |
VV Manager LLC
VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Finance |
